ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 23 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $68,000 | -10.5% | 64,000 | 0.0% | 0.00% | – |
| Q2 2019 | $76,000 | +8.6% | 64,000 | 0.0% | 0.00% | – |
| Q1 2019 | $70,000 | +11.1% | 64,000 | 0.0% | 0.00% | – |
| Q4 2018 | $63,000 | -6.0% | 64,000 | 0.0% | 0.00% | – |
| Q3 2018 | $67,000 | -97.7% | 64,000 | -97.5% | 0.00% | -100.0% |
| Q2 2018 | $2,913,000 | +132.9% | 2,564,000 | +124.7% | 0.00% | – |
| Q1 2018 | $1,251,000 | +8.6% | 1,141,000 | +14.1% | 0.00% | – |
| Q4 2017 | $1,152,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 59,455 | $68,522,000 | 3.54% |
| DLD Asset Management, LP | 4,500,000 | $5,185,000 | 1.70% |
| Worth Venture Partners, LLC | 945,000 | $1,100,000 | 1.18% |
| Perceptive Advisors | 7,500,000 | $8,700,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,439,000 | $17,789,000 | 0.23% |
| Allianz Asset Management GmbH | 35,165,000 | $40,795,000 | 0.04% |
| GABELLI FUNDS LLC | 1,500,000 | $1,740,000 | 0.01% |
| AQR Arbitrage LLC | 525,000 | $605,000 | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9,000,000 | $10,328,000 | 0.01% |
| Edge Advisors, LLC | 33,000 | $38,000 | 0.01% |